Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded Healthcare sector company. As of July 13, 2026, AMPH trades at $19.23 with a market cap of $825.42M and a P/E ratio of 10.95. AMPH moved +0.00% today. Year to date, AMPH is -30.67%; over the trailing twelve months it is -15.71%. Its 52-week range spans $16.65 to $46.43. Analyst consensus is neutral with an average price target of $20.40. Rallies surfaces AMPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AMPH shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $19.23 |
| Market Cap | $825.42M |
| P/E Ratio | 10.95 |
| EPS | $1.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.43 |
| 52-Week Low | $16.65 |
| Volume | 14.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $720.53M |
| Net Income | $79.23M |
| Gross Margin | 47.34% |
6 analysts cover AMPH: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $20.40.